Cargando…
Use of Cyclosporine Therapy in Dermatology During COVID-19 Pandemic
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AEDV. Published by Elsevier España, S.L.U.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809675/ https://www.ncbi.nlm.nih.gov/pubmed/35132273 http://dx.doi.org/10.1016/j.ad.2021.10.009 |
| _version_ | 1784644072203354112 |
|---|---|
| author | Pathania, Y.S. |
| author_facet | Pathania, Y.S. |
| author_sort | Pathania, Y.S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8809675 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AEDV. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88096752022-02-03 Use of Cyclosporine Therapy in Dermatology During COVID-19 Pandemic Pathania, Y.S. Actas Dermosifiliogr Opinion Article AEDV. Published by Elsevier España, S.L.U. 2022 2022-02-02 /pmc/articles/PMC8809675/ /pubmed/35132273 http://dx.doi.org/10.1016/j.ad.2021.10.009 Text en © 2022 AEDV. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Opinion Article Pathania, Y.S. Use of Cyclosporine Therapy in Dermatology During COVID-19 Pandemic |
| title | Use of Cyclosporine Therapy in Dermatology During COVID-19 Pandemic |
| title_full | Use of Cyclosporine Therapy in Dermatology During COVID-19 Pandemic |
| title_fullStr | Use of Cyclosporine Therapy in Dermatology During COVID-19 Pandemic |
| title_full_unstemmed | Use of Cyclosporine Therapy in Dermatology During COVID-19 Pandemic |
| title_short | Use of Cyclosporine Therapy in Dermatology During COVID-19 Pandemic |
| title_sort | use of cyclosporine therapy in dermatology during covid-19 pandemic |
| topic | Opinion Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809675/ https://www.ncbi.nlm.nih.gov/pubmed/35132273 http://dx.doi.org/10.1016/j.ad.2021.10.009 |
| work_keys_str_mv | AT pathaniays useofcyclosporinetherapyindermatologyduringcovid19pandemic |